Skip to content

WARVAN: what changed

BE 0434.428.554NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€48,579
2024 · €134+€48,445
Equity
-€142,608
2024 · -€191,187+€48,579
Cash
€72,526
2024 · €43,869+€28,657
Balance sheet total
€251,999
2024 · €235,803+€16,196

Largest movements

2024 to 2025
Assets
  • Cash +€28,657

    up €28,657 (+65.3%), from €43,869 to €72,526

    mainly Net result for the year (+€48,579) and Accrued charges and deferred income (+€12,223)

  • Stocks and contracts -€4,896

    down €4,896 (-3.3%), from €148,131 to €143,235

  • Receivables within one year -€3,973

    down €3,973 (-16.3%), from €24,400 to €20,428

    of which Trade receivables: -€8,376

  • Deferred charges and accrued income -€2,666

    down €2,666 (-64.5%), from €4,133 to €1,467

Equity and liabilities
  • Profit (loss) carried forward +€48,579

    up €48,579 (+8.2%), from -€595,793 to -€547,214

  • Trade debts -€30,168

    down €30,168 (-92.2%), from €32,738 to €2,570

  • Other debts -€13,370

    down €13,370 (-22.6%), from €59,214 to €45,844

  • Accrued charges and deferred income +€12,223

    up €12,223 (+123%), from €9,900 to €22,123

Income statement
  • Staff costs -€63,000

    down €63,000 (-87.5%), from €71,991 to €8,991

  • Gross operating margin -€13,652

    down €13,652 (-17.3%), from €78,691 to €65,039

  • Other operating charges +€874

    up €874 (+64.2%), from €1,363 to €2,237

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €134
Gross operating margin -€13,652
Staff costs +€63,000
Depreciation -€770
Other operating charges -€874
Other operating items +€1,570
Financial income -€477
Financial charges -€352
Result 2025 €48,579
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€31,164
Investment -€2,507
Financing €0
Cash 2024 €43,869
Net result for the year +€48,579
Depreciation +€3,433
Stocks and contracts +€4,896
Receivables within one year +€3,973
Deferred charges and accrued income +€2,666
Trade debts -€30,168
Tax, wage and social debts -€1,068
Other debts -€13,370
Accrued charges and deferred income +€12,223
Investment in fixed assets (net) -€2,507
Cash 2025 €72,526
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €235,803 €251,999 +€16,196 +6.9%
Fixed assets 21/28 €15,270 €14,344 -€926 -6.1%
Tangible fixed assets 22/27 €12,770 €11,844 -€926 -7.3%
Land and buildings 22 €4,530 €6,105 +€1,575 +34.8%
Plant, machinery and equipment 23 €7,159 €5,199 -€1,961 -27.4%
Other tangible fixed assets 26 €1,081 €541 -€540 -50.0%
Financial fixed assets 28 €2,500 €2,500 = 0.0%
Current assets 29/58 €220,533 €237,655 +€17,122 +7.8%
Stocks and contracts in progress 3 €148,131 €143,235 -€4,896 -3.3%
Stocks 30/36 €148,131 €143,235 -€4,896 -3.3%
Amounts receivable within one year 40/41 €24,400 €20,428 -€3,973 -16.3%
Trade receivables 40 €18,310 €9,934 -€8,376 -45.7%
Other amounts receivable 41 €6,090 €10,494 +€4,403 +72.3%
Cash at bank and in hand 54/58 €43,869 €72,526 +€28,657 +65.3%
Deferred charges and accrued income 490/1 €4,133 €1,467 -€2,666 -64.5%
Total equity and liabilities 10/49 €235,803 €251,999 +€16,196 +6.9%
Equity 10/15 -€191,187 -€142,608 +€48,579 +25.4%
Contributions 10/11 €350,000 €350,000 = 0.0%
Reserves 13 €54,607 €54,607 = 0.0%
Non-distributable reserves 130/1 €1,859 €1,859 = 0.0%
Reserves not available under the articles 1311 €1,859 €1,859 = 0.0%
Distributable reserves 133 €52,747 €52,747 = 0.0%
Profit (loss) carried forward 14 -€595,793 -€547,214 +€48,579 +8.2%
Amounts payable 17/49 €426,989 €394,607 -€32,382 -7.6%
Amounts payable after more than one year 17 €321,500 €321,500 = 0.0%
Financial debts 170/4 €321,500 €321,500 = 0.0%
Amounts payable within one year 42/48 €95,589 €50,984 -€44,606 -46.7%
Trade debts 44 €32,738 €2,570 -€30,168 -92.2%
Suppliers 440/4 €32,738 €2,570 -€30,168 -92.2%
Taxes, remuneration and social security 45 €3,637 €2,570 -€1,068 -29.4%
Taxes 450/3 €813 €1,396 +€583 +71.8%
Remuneration and social security 454/9 €2,825 €1,174 -€1,651 -58.5%
Other amounts payable 47/48 €59,214 €45,844 -€13,370 -22.6%
Accrued charges and deferred income 492/3 €9,900 €22,123 +€12,223 +123%
Remuneration, social security and pensions 62 €71,991 €8,991 -€63,000 -87.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,663 €3,433 +€770 +28.9%
Other operating charges 640/8 €1,363 €2,237 +€874 +64.2%
Non-recurring operating charges 66A €1,570 - -€1,570
Gross operating margin 9900 €78,691 €65,039 -€13,652 -17.3%
Operating profit (loss) 9901 €1,105 €50,379 +€49,274 +4,460%
Financial income 75/76B €922 €446 -€477 -51.7%
Recurring financial income 75 €922 €446 -€477 -51.7%
Financial charges 65/66B €1,894 €2,246 +€352 +18.6%
Recurring financial charges 65 €1,894 €2,246 +€352 +18.6%
Profit (loss) for the period before taxes 9903 €134 €48,579 +€48,445 +36,283%
Profit (loss) for the period 9904 €134 €48,579 +€48,445 +36,283%
Profit (loss) for the period to be appropriated 9905 €134 €48,579 +€48,445 +36,283%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€142,608
Capitalised earnings €42,493 to €59,490

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€142,608
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€142,608

Capitalised earnings

net result for the year (9904)
2025
€48,579
2024
€134
excluding non-recurring income and charges
€1,704
2023
-€32,436
2022
€16,575
2021
€46,119
Average result, excluding non-recurring income and charges
€5,949
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€42,493 / €49,575 / €59,490

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.